Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 4Phase 1 4Phase 4 2Phase NA 1Phase 2/3 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 10Other hematologic neoplasm 7Genitourinary 6Plasma cell 3Dermatologic 2Thoracic 1Endocrine 1CNS 1

Conditions

Waldenstrom Macroglobulinemia 1Subcutaneous panniculitis-like T-cell lymphoma 1Skin Neoplasms 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Imiquimod 15Aminolevulinic Acid 8Fluorouracil 6Diclofenac 63-ingenyl angelate 6Nivolumab 5Cryotherapy 5tirbanibulin 4methyl 5-aminolevulinate 4Sirolimus 4denileukin diftitox 3aldesleukin 3Photochemotherapy 3Ipilimumab 3Blood Specimen Collection 3relatlimab 2Vemurafenib 2Tacrolimus 2Prednisone 2Ointments 2Methotrexate 2Immune Checkpoint Inhibitors 2HhAntag691 2Gels 2Cyclosporine 2Cryosurgery 2trametinib 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1technetium Tc 99m nanocolloid 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Prednisone × Dermatologic × Clear all
NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Dana-Farber Cancer Institute

Phase 4 Not yet recruiting
80 enrolled
DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT01746992 2017-11-14

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Ruijin Hospital

Phase 4 Unknown
200 enrolled
DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡